NLRP3 Inflammasome Overactivation in Patients with Aneurysmal Subarachnoid Hemorrhage
| Autor: | Elena Díaz-García, Kapil Nanwani-Nanwani, Sara García-Tovar, Enrique Alfaro, Eduardo López-Collazo, Manuel Quintana-Díaz, Francisco García-Rio, Carolina Cubillos-Zapata |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Popis: | Aneurysmal subarachnoid hemorrhage (aSAH) is an uncommon and severe subtype of stroke leading to the loss of many years of productive life. We analyzed NLRP3 activity as well as key components of the inflammasome cascade in monocytes and plasma from 28 patients with aSAH and 14 normal controls using flow cytometry, western blot, ELISA, and qPCR technologies. Our data reveal that monocytes from patients with aSAH present an overactivation of the NLRP3 inflammasome, which results in the presence of high plasma levels of interleukin (IL)-1β, IL-18, gasdermin D, and tissue factor. Although further research is needed, we propose that serum tissue factor concentration might be a useful prognosis biomarker for clinical outcome, and for Tako-Tsubo cardiomyopathy and cerebral vasospasm prediction. Remarkably, MCC-950 inhibitor effectively blocks NLRP3 activation in aSAH monocyte culture and supresses tissue factor release to the extracellular space. Finally, our findings suggest that NLRP3 activation could be due to the release of erythrocyte breakdown products to the subarachnoid space during aSAH event. These data define NLRP3 activation in monocytes from aSAH patients, indicating systemic inflammation that results in serum TF upregulation which in turns correlates with aSAH severity and might serve as a prognosis biomarker for aSAH clinical outcome and for cerebral vasospasm and Tako-Tsubo cardiomyopathy prediction. This work was supported by the following fundings: Fondo de Investigación Sanitario (FIS)-Fondos FEDER, Spain: PI19/01612 (F.G-R.) and CP18/00028 and PI19-01363 (C.C-Z.) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|